Co-Authors
This is a "connection" page, showing publications co-authored by SHARON HERMES GIORDANO and DANIEL GOMEZ.
Connection Strength
0.430
-
Time to treatment as a quality metric in lung cancer: Staging studies, time to treatment, and patient survival. Radiother Oncol. 2015 May; 115(2):257-63.
Score: 0.128
-
Adherence to national guidelines for antiemesis prophylaxis in patients undergoing chemotherapy for lung cancer: a population-based study. Cancer. 2013 Apr 01; 119(7):1428-36.
Score: 0.108
-
Trends and Outcomes of Proton Radiation Therapy Use for Non-Small Cell Lung Cancer. Int J Part Ther. 2018; 5(2):18-27.
Score: 0.041
-
Racial disparities in guideline-concordant cancer care and mortality in the United States. Adv Radiat Oncol. 2018 Jul-Sep; 3(3):221-229.
Score: 0.039
-
Predictors of trimodality therapy and trends in therapy for malignant pleural mesothelioma. Eur J Cardiothorac Surg. 2018 05 01; 53(5):960-966.
Score: 0.039
-
Long-Term Survival Outcomes of Cancer-Directed Surgery for Malignant Pleural Mesothelioma: Propensity Score Matching Analysis. J Clin Oncol. 2017 Oct 10; 35(29):3354-3362.
Score: 0.037
-
Influence of Age on Guideline-Concordant Cancer Care for Elderly Patients in the United States. Int J Radiat Oncol Biol Phys. 2017 07 15; 98(4):748-757.
Score: 0.036